Verve Therapeutics
VERV
#7245
Rank
C$0.53 B
Marketcap
$6.00
Share price
-8.42%
Change (1 day)
-65.32%
Change (1 year)

EPS for Verve Therapeutics (VERV)

EPS in 2023 (TTM): -$4.28

According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.54. In 2022 the company made an earnings per share (EPS) of -$4.19 a decrease over its 2021 EPS that were of -$3.62.

EPS history for Verve Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.282.22%
2022-$4.1915.54%
2021-$3.6261.32%
2020-$2.25